Prenetics
{{company.company_channel.channel_name}}
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Prenetics Announces Fourth Quarter and Full Year 2023 Financial Results 2024-04-01 19:30
Prenetics Announces MOU for a Strategic Investment and 5-Year Research Collaboration with Metavisionaries to Pioneer R&D on the International Space Station 2024-02-09 22:44
Prenetics Announces Third Quarter 2023 Financial Results 2023-11-20 19:30
Prenetics Announces Second Quarter 2023 Financial Results 2023-09-15 19:10
A World's First: The Miss Hong Kong Pageant 2023 Unveiled Contestants' CircleDNA Results Live on Television 2023-08-29 12:46
Prenetics and Globally Renowned Scientist Prof. Dennis Lo Establish US$200m Joint Venture "Insighta" for Breakthrough Multi-Cancer Early Detection Screening 2023-06-26 08:45
Prenetics Announces First Quarter 2023 Financial Results 2023-06-05 19:20
Prenetics Announces Fourth Quarter and Full Year 2022 Financial Results 2023-03-14 20:56
Prenetics Announces Formation of Scientific Advisory Board to Support New Business Strategy in Precision Oncology 2023-03-02 20:00
Prenetics Announces Dr. Bayju Thakar as Chief Executive Officer of Prenetics EMEA 2023-01-19 18:56
Prenetics Owned ACT Genomics Receives FDA Clearance for ACTOnco, the First Asia-Based Company to Receive Clearance for a Comprehensive Genomic Profiling Test for All Solid Tumors 2023-01-10 21:05
Prenetics Acquires ACT Genomics, Creating a Leader in Comprehensive Cancer Genetics and Precision Oncology 2022-12-16 19:56
Prenetics Announces US$20 Million Stock Repurchase Program and Inclusion into the MSCI Global Micro Cap Index 2022-11-30 22:15
Prenetics Announces Record Third Quarter 2022 Financial Results and Raises Full Year 2022 Revenue and EBITDA Guidance 2022-11-10 21:30
Prenetics Announces Second Quarter 2022 Financial Results and Raises Full Year Adjusted EBITDA Outlook 2022-09-09 23:17
Prenetics Launches Circle Snapshot, Simple At-home Blood Tests Using the World's First Push-Button and Painless Blood Collection Device 2022-08-08 16:45
Prenetics Launches ColoClear, a Non-Invasive Stool DNA Test to Detect Early Signs of Colorectal Cancer in Hong Kong 2022-06-09 00:56
Prenetics Announces First Quarter 2022 Financial Results After a Successful Listing on the Nasdaq under the Ticker "PRE" 2022-06-06 21:55
New Horizon Health Partners with Prenetics in Hong Kong to Launch ColoClear, a Non-Invasive Stool DNA Test to Detect Colon Cancer 2022-05-23 20:46
Prenetics and Artisan Acquisition Corp. Announce Shareholder Approval of Business Combination, To Begin Trading on Nasdaq on May 18 Under the Ticker "PRE" 2022-05-11 09:00
1 2